Skip to content

Opening book details…

About this Medicine article

Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: a California Cancer Consortium Trial. by Mohrbacher, Ann; Yang, Allen S; Groshen, Susan; Kummar, Shivaani; Gutierrez, Martin E; Kang, Min H.; Tsao-Wei, Denice; Reynolds, C. Patrick; Newman, Edward; Maurer, Barry J is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Mohrbacher, Ann; Yang, Allen S; Groshen, Susan; Kummar, Shivaani; Gutierrez, Martin E; Kang, Min H.; Tsao-Wei, Denice; Reynolds, C. Patrick; Newman, Edward; Maurer, Barry J
Publisher
American Association for Cancer Research; American Association for Cancer Research (AACR) (ISSN 1078-0432)
Published
2017
Language
EN
Field
Medicine (Health Sciences)

More by Mohrbacher, Ann; Yang, Allen S; Groshen, Susan; Kummar, Shivaani; Gutierrez, Martin E; Kang, Min H.; Tsao-Wei, Denice; Reynolds, C. Patrick; Newman, Edward; Maurer, Barry J

Browse all works by Mohrbacher, Ann; Yang, Allen S; Groshen, Susan; Kummar, Shivaani; Gutierrez, Martin E; Kang, Min H.; Tsao-Wei, Denice; Reynolds, C. Patrick; Newman, Edward; Maurer, Barry J